Point72 Asset Management L.P. purchased a new stake in shares of Colgate-Palmolive (NYSE:CL) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 24,900 shares of the company’s stock, valued at approximately $1,814,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Blue Chip Partners Inc. boosted its holdings in shares of Colgate-Palmolive by 0.4% during the second quarter. Blue Chip Partners Inc. now owns 1,813 shares of the company’s stock worth $134,000 after purchasing an additional 8 shares during the period. AlphaMark Advisors LLC boosted its holdings in shares of Colgate-Palmolive by 1.5% during the second quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock worth $126,000 after purchasing an additional 25 shares during the period. Weatherstone Capital Management boosted its holdings in shares of Colgate-Palmolive by 0.7% during the second quarter. Weatherstone Capital Management now owns 4,069 shares of the company’s stock worth $302,000 after purchasing an additional 28 shares during the period. Dorsey & Whitney Trust CO LLC boosted its holdings in shares of Colgate-Palmolive by 0.6% during the second quarter. Dorsey & Whitney Trust CO LLC now owns 5,642 shares of the company’s stock worth $419,000 after purchasing an additional 34 shares during the period. Finally, Jackson Grant Investment Advisers Inc. boosted its holdings in shares of Colgate-Palmolive by 0.5% during the second quarter. Jackson Grant Investment Advisers Inc. now owns 7,028 shares of the company’s stock worth $521,000 after purchasing an additional 35 shares during the period. Institutional investors and hedge funds own 72.86% of the company’s stock.

In other Colgate-Palmolive news, Director Stephen I. Sadove sold 20,780 shares of the firm’s stock in a transaction that occurred on Monday, November 6th. The shares were sold at an average price of $70.52, for a total transaction of $1,465,405.60. Following the completion of the transaction, the director now owns 36,268 shares of the company’s stock, valued at $2,557,619.36. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Justin Skala sold 126,393 shares of the firm’s stock in a transaction that occurred on Thursday, November 9th. The shares were sold at an average price of $72.97, for a total transaction of $9,222,897.21. Following the transaction, the chief operating officer now directly owns 262,361 shares of the company’s stock, valued at approximately $19,144,482.17. The disclosure for this sale can be found here. Insiders have sold 181,950 shares of company stock valued at $13,237,385 in the last ninety days. Insiders own 1.02% of the company’s stock.

CL has been the subject of a number of analyst reports. Citigroup dropped their target price on shares of Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating for the company in a report on Thursday, November 2nd. Zacks Investment Research upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $81.00 target price for the company in a report on Monday, October 23rd. KeyCorp reiterated a “hold” rating on shares of Colgate-Palmolive in a report on Saturday, November 25th. Macquarie raised shares of Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 price target for the company in a research note on Tuesday, December 19th. Finally, SunTrust Banks raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and increased their price target for the stock from $65.00 to $85.00 in a research note on Wednesday, October 11th. Two investment analysts have rated the stock with a sell rating, thirteen have given a hold rating and six have issued a buy rating to the company. The company has an average rating of “Hold” and a consensus price target of $76.45.

Colgate-Palmolive (CL) opened at $77.50 on Friday. Colgate-Palmolive has a one year low of $63.43 and a one year high of $77.91. The stock has a market cap of $67,289.20, a PE ratio of 29.92, a P/E/G ratio of 3.20 and a beta of 0.80. The company has a quick ratio of 0.92, a current ratio of 1.23 and a debt-to-equity ratio of 24.42.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, October 27th. The company reported $0.73 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.73. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The company had revenue of $3.97 billion during the quarter, compared to the consensus estimate of $3.94 billion. During the same period in the prior year, the firm earned $0.73 earnings per share. Colgate-Palmolive’s revenue was up 2.8% on a year-over-year basis. analysts anticipate that Colgate-Palmolive will post 2.87 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Thursday, February 15th. Shareholders of record on Tuesday, January 23rd will be paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.06%. The ex-dividend date is Monday, January 22nd. Colgate-Palmolive’s dividend payout ratio is 61.78%.

WARNING: “Point72 Asset Management L.P. Takes Position in Colgate-Palmolive (CL)” was reported by Daily Political and is owned by of Daily Political. If you are reading this piece of content on another site, it was copied illegally and republished in violation of US & international trademark & copyright law. The correct version of this piece of content can be viewed at https://www.dailypolitical.com/2018/01/20/point72-asset-management-l-p-takes-position-in-colgate-palmolive-cl.html.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.